Literature DB >> 32910350

NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics.

Kristine S Wong1, Adrian Mariño-Enriquez1, Jason L Hornick1, Vickie Y Jo2.   

Abstract

Acinic cell carcinoma (AciCC) harbors a recurrent t(4;9)(q13;q31) translocation, which leads to upregulation of Nuclear Receptor Subfamily 4 Group A Member 3 (NR4A3). Previous work on tissue microarrays suggests that NR4A3 immunohistochemistry (IHC) may be useful in the diagnosis of AciCC. Thus far, only a single study has evaluated the utility of NR4A3 immunohistochemistry (IHC) in the diagnosis of AciCC, using a tissue microarray to assess most non-AciCC tumor types. Herein we evaluate the diagnostic performance of NR4A3 IHC for AciCC in a large cohort of 157 salivary gland tumors, using whole tissue sections. The cohort consisted of 37 AciCC (6 of them (16%) with high grade transformation), 30 secretory carcinomas (SC), and 90 additional salivary gland tumors, including mucoepidermoid carcinomas (MEC), polymorphous adenocarcinomas (PAC), pleomorphic adenomas (PA), salivary duct carcinomas (SDC), and adenoid cystic carcinomas (AdCC). NR4A3 nuclear staining by IHC was considered positive if present in more than 5% of tumor cells. Overall, 92% of AciCC (34/37) expressed NR4A3 by IHC, with strong (89%) or moderate (3%) nuclear staining, yielding a sensitivity of 92%. IHC detected NR4A3 expression in all cases of recurrent/metastatic AciCC and tumors with high grade transformation. Importantly, all SC were negative for NR4A3 IHC, with no staining in 28/30 cases and weak focal staining, in < 5% of cells, in 2/30 (7%). Similarly, all MEC (20/20), SDC (20/20) and AdCC (10/10) were negative for NR4A3 by IHC, as were most PA (18/20; 15%) and PAC (18/20; 5%). Two PA and two PAC showed multifocal expression of NR4A3 in more than 5% of cells, of weak intensity in 3 cases and moderate in 1 PAC, yielding an overall specificity of 97% for NR4A3 IHC for the diagnosis of AciCC. In conclusion, NR4A3 is a highly sensitive and specific immunohistochemical marker for AciCC; moderate to strong and/or diffuse NR4A3 expression is a consistent and diagnostic feature of AciCC.

Entities:  

Keywords:  Acinic cell carcinoma; FISH; IHC; NR4A3; Salivary gland; Secretory carcinoma

Mesh:

Substances:

Year:  2020        PMID: 32910350      PMCID: PMC8134602          DOI: 10.1007/s12105-020-01213-4

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  33 in total

1.  Dedifferentiated acinic cell carcinoma of the parotid gland: a distinct rarely described entity.

Authors:  J D Henley; W A Geary; C L Jackson; C D Wu; D R Gnepp
Journal:  Hum Pathol       Date:  1997-07       Impact factor: 3.466

2.  Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.

Authors:  Kalyani R Patel; Isaac H Solomon; Samir K El-Mofty; James S Lewis; Rebecca D Chernock
Journal:  Hum Pathol       Date:  2013-09-10       Impact factor: 3.466

3.  Fine needle aspiration cytology of dedifferentiated acinic cell carcinoma of the parotid gland: a case report.

Authors:  Pilar González-Peramato; José A Jiménez-Heffernan; Pilar López-Ferrer; Blanca Vicandi; José M Viguer
Journal:  Acta Cytol       Date:  2006 Jan-Feb       Impact factor: 2.319

4.  Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.

Authors:  Diana Bell; Renata Ferrarotto; Li Liang; Ryan P Goepfert; Jie Li; Jing Ning; Russell Broaddus; Randal S Weber; Adel K El-Naggar
Journal:  Virchows Arch       Date:  2019-08-19       Impact factor: 4.064

5.  Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.

Authors:  Andre Pinto; Vania Nosé; Claudia Rojas; Yao-Shan Fan; Carmen Gomez-Fernandez
Journal:  Mod Pathol       Date:  2013-06-28       Impact factor: 7.842

6.  Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.

Authors:  Florian Haller; Alena Skálová; Stephan Ihrler; Bruno Märkl; Matthias Bieg; Evgeny A Moskalev; Ramona Erber; Susanne Blank; Christa Winkelmann; Simone Hebele; Martina Baněčková; Stefan Wiemann; Sarina Müller; Johannes Zenk; Roland Eils; Heinrich Iro; Arndt Hartmann; Abbas Agaimy
Journal:  Am J Surg Pathol       Date:  2019-09       Impact factor: 6.394

7.  Recurrent rearrangements of 11q14-22 in mucoepidermoid carcinoma.

Authors:  A Nordkvist; H Gustafsson; M Juberg-Ode; G Stenman
Journal:  Cancer Genet Cytogenet       Date:  1994-06

8.  Factors influencing survival in acinic cell carcinoma: a retrospective survival analysis of 2061 patients.

Authors:  Vincent L Biron; Eric J Lentsch; Daniel R Gerry; Arnaud F Bewley
Journal:  Head Neck       Date:  2014-07-28       Impact factor: 3.147

9.  Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma.

Authors:  Akeesha A Shah; Bruce M Wenig; Robin D LeGallo; Stacey E Mills; Edward B Stelow
Journal:  Head Neck Pathol       Date:  2014-07-31

Review 10.  "Dedifferentiation" and high-grade transformation in salivary gland carcinomas.

Authors:  Toshitaka Nagao
Journal:  Head Neck Pathol       Date:  2013-07-03
View more
  4 in total

Review 1.  The evolving role of molecular pathology in the diagnosis of salivary gland tumours with potential pitfalls.

Authors:  Kanwalpreet Kaur; Shailee Mehta; Sangita Vanik; Priti Trivedi; Nirmalya Banerjee; Harsh Dhar; Sourav Datta; Subhadeep Karanjai
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-10       Impact factor: 2.503

2.  Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature.

Authors:  Juan C Hernandez-Prera; Daryoush Saeed-Vafa; Amin Heidarian; Kathleen Gewandter; Kristen Otto; Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2021-08-19

3.  NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens.

Authors:  Kartik Viswanathan; Shaham Beg; Bing He; Taotao Zhang; Richard Cantley; Daniel J Lubin; Qiuying Shi; Zahra Maleki; Saeed Asiry; Rema Rao; Nora Katabi; Masato Nakaguro; William C Faquin; Peter M Sadow; Momin T Siddiqui; Theresa Scognamiglio
Journal:  Am J Clin Pathol       Date:  2022-01-06       Impact factor: 5.400

Review 4.  The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in Cancer.

Authors:  Stephen Safe; Keshav Karki
Journal:  Mol Cancer Res       Date:  2020-10-26       Impact factor: 6.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.